Compound Libraries

-A unique collection of 522 natural product molecules for high throughput screening (HTS) and high content screening (HCS); - Novel structures with limited related research, offering significant research value. -HNMR, LCMS and HPLC validated to ensure high purity and quality.

-A unique collection of 53200 approved and clinical drugs for high throughput screening (HTS) ; -Covers 300+ targets and over 500 sub-libraries of specific-targeted compounds, suitable for diverse screening purposes. -Over 1,900 compound scaffolds and 600+ unique heterocyclic structures for enhanced screening probability and novelty. -Rigorous multi-filter screening ensures each sub-library contains 25-250 compounds with good drug-like properties. -NMR and HPLC validated to ensure high purity and quality. -Multiple specifications are available, including 200μL * 10mM (in DMSO), 100 μL* 10mM (in DMSO) etc.

- A unique collection of over 12,000 covalent compounds with the number continuously increasing; - Compounds with poor diversity are excluded based on structural characteristics; - Covers three sub-libraries: Covalent Inhibitor General Library, Covalent Inhibitor Smart Library, and sp3-richβ-lactam Library; - All compounds are in stock, fast delivered and highly cost-effective; - NMR and LC-MS validated to ensure high purity and quality.

- A unique collection of 1867 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study; - Targets include PARP, VEGF, PD-1, HER2, etc; - Some compounds have already been launched or are in clinical phases. - Detailed compound information on structures, targets, IC50 and activity descriptions. - NMR and HPLC/LCMS validated to ensure high purity and quality.

- A unique collection of 1000 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; - Effective tool for research in endogenous metabolism-related diseases, exploring the tumorigenesis, and drug discovery; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality.

- 672 compounds related to neuronal differentiation, suitable for the drug development of nervous system disease. - Pathway targets include Notch, Wnt, Hedgehog, etc. - Some compounds are already on the market or in clinical trials. - Detailed documentation, including compound structures, target information, and activity descriptions. - Various detection techniques such as NMR, HPLC, LCMS, etc., ensure correct product structure, high purity, and reduce false positives.

- A unique collection of 1072 compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis. - Compounds sourced from over 40 TCMs with blood circulation-promoting and blood stasis-removing effects, including safflower, turmeric, Garden Balsam Seed, myrrh, etc. - With diverse structures, encompassing terpenes, alkaloids, flavonoids, and other structurally diverse compounds. - Detailed compound information on structures, targets, IC50 and activity descriptions. - NMR and HPLC/LCMS validated to ensure high purity and quality. - Comprehensive instructions on product handling, solvent selection, storage methods and concentration choice for initial screening.

- 1163 compounds associated with depression that can be used for high-throughput and high-content screening; - Some of the compounds are marketed or have entered the clinical phase; - Detailed instructions, compound structure, target information, activity description, etc; - Multiple detection techniques such as NMR, HPLC/LCMS to ensure correct structure and high purity of the product and reduce false positives.